GL1X · GenesisL1 explorer

MolNFT v1 · #162470 · protein

Human tnik in complex with compound 9

6RA5 · TRAF2 and nck-interacting protein kinase: “Human tnik in complex with compound 9”. X-ray diffraction, 2 ligands (JWE, MG), 5 pockets (best druggability 0.70). MolNFT v1 #162470 on GenesisL1: 3D structure, binding sites and pockets…

PDB
6RA5
Type
protein
Length
578 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
TRAF2 and nck-interacting protein kinase
EC
2.7.11.1
UniProt
Q9UKE5
Ligands
JWE, MG
Pockets
5 · best druggability 0.70

Structure

x-ray diffraction · 2 distinct chains · 38% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATRAF2 and nck-interacting protein kinase (EC 2.7.11.1)protein29537% helix, 18% strandQ9UKE5
BTRAF2 and nck-interacting protein kinase (EC 2.7.11.1)protein28340% helix, 18% strandQ9UKE5

Ligands and binding sites

  • JWE · 5-bromanyl-2-(2-fluoranylpyridin-4-yl)-1,7-naphthyridin-8-amine · ligand · chains A
  • MG · Magnesium ion · metal · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13960.700.8261empty
21040.640.8926empty
32040.600.8130JWE
41540.470.7618empty
5860.350.7521empty

Interfaces

1 interface between chains.

  • A–B · 446 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 modified (phosphorylation).

Compared structures

  • 6RA5 · Human tnik in complex with compound 9 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UKE5 · AlphaFold monomer V2.0 prediction for TRAF2 and nck-interacting protein kinase (Q9UKE5) · a predicted model of the same protein · chain B against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.